Patent · US Active

Methods for characterizing loss of antigen presentation

US11920194B2 · kind B2 · utility

0Cited by
0References
23Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 1, 2018
Grant dateMar 5, 2024
Priority date
Expiry dateNov 27, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This invention relates to methods for screening for a genotype for loss of antigen presentation via MHC class I in a subject and/or respectively detecting a subject's increased risk of resistance against immunotherapy such as against vaccination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.